Metabolic-dimension CKM staging and cardiometabolic components predict incident MASLD: a longitudinal community-based cohort study
Xinyang Long, Meihui Wu, YeMei Mo, Yingqi Zhang, Yining Lin, Qiuling Zhang, Zengnan Mo · 2026
Read Metabolic-dimension CKM staging and cardiometabolic components predict incident MASLD: a longitudinal community-based cohort study by Xinyang Long, Meihui Wu, YeMei Mo, Yingqi Zhang, Yining Lin, Qiuling Zhang, Zengnan Mo (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13236620.txt.
Description
Xinyang Long and colleagues followed in 2026 a community cohort in southern China to test whether combined metabolic risk predicts new fatty liver disease. Their staging system counted five heart, kidney, and metabolic components because deeper organ testing was unavailable. More than two thousand participants free of fatty liver at baseline were tracked for a median of over two and a half years. Ultrasound-defined fatty liver served as a check against definition overlap.
Each added metabolic component raised the odds of having fatty liver at the starting survey. Higher stage at baseline more than doubled the risk of developing the disease during follow-up. Excess body fat was the single strongest component predictor, followed by high blood triglycerides. The forward link held when the outcome was narrowed to ultrasound fatty liver alone. The reverse direction, from liver disease to stage progression, faded after accounting for body mass.
Catalog record
| CREATOR | Xinyang Long, Meihui Wu, YeMei Mo, Yingqi Zhang, Yining Lin, Qiuling Zhang, Zengnan Mo |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 48 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |